查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1981347

骨水泥及黏合劑市場：全球市場按產品類型、技術、應用、最終用戶和分銷管道分類的預測 - 2026-2032年

Bone Cement & Glue Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，骨水泥和黏合劑市場價值將達到 21.1 億美元，到 2026 年將成長到 22.5 億美元，到 2032 年將達到 32.9 億美元，複合年成長率為 6.58%。

主要市場統計數據
基準年 2025 21.1億美元
預計年份：2026年 22.5億美元
預測年份 2032 32.9億美元
複合年成長率 (%) 6.58%

本介紹部分清楚地說明了生物材料的創新和臨床工作流程的進步如何重新定義骨水泥和外科黏合劑的選擇。

隨著生物材料技術的進步與外科手術流程的不斷演進，骨水泥和黏合劑領域正吸引臨床、監管和商業相關人員的廣泛關注。本報告首先概述了骨水泥和黏合劑在現代整形外科、顱顏外科、口腔外科和脊椎外科治療流程中的作用，然後闡述了成分、劑型和最終用戶環境的差異如何影響其應用和臨床療效。

生物材料的進步、手術流程向門診轉移以及更嚴格的監管要求，正在如何改變市場動態和臨床應用？

過去幾年，在材料科學的突破、手術流程的改進以及監管力度的加強的推動下，骨水泥和外科黏合劑的競爭格局和臨床環境發生了翻天覆地的變化。生物活性配方的創新已從概念驗證發展到常規臨床評估階段，從而實現了能夠促進骨整合並提供可控吸收特性的材料。同時，注射劑和可塑形劑等給藥機制的改進，也擴大了這些產品在微創手術和門診手術的應用範圍。

我們將評估近期關稅措施如何促使各產業進行策略供應鏈重組、採購地理多元化和商業合約轉型。

2025年關稅的實施和貿易政策的變化，為骨水泥和骨接合劑產業的供應鏈策略帶來了顯著的轉捩點。中間體和成品的進口關稅增加了依賴跨境生產聚合物、活性添加劑和包裝材料的製造商的接收成本。為此，各公司正在重新審視籌資策略，並加速生產能力的地域多角化，以降低關稅波動帶來的風險，確保及時向關鍵臨床客戶交付產品。

詳細的細分分析揭示了產品化學特性、臨床應用、最終用戶環境、技術類型和分銷管道如何形成差異化的進入管道。

細分市場分析揭示了產品的細微性能特徵和分銷管道差異，這些差異取決於產品的化學性質、臨床應用、終端用戶環境、技術分類和分銷模式。按產品類型分類，市場包括丙烯酸骨水泥和磷酸鈣骨水泥。丙烯酸骨水泥可進一步細分為用於感染控制通訊協定的含抗生素配方和用於標準固定需求的不含抗生素配方。另一方面，磷酸鈣骨水泥則以注射型和可塑型兩種形式提供，以滿足微創給藥和術中塑形的需求。

美洲、歐洲、中東和非洲以及亞太地區的趨勢將影響採用率、監管重點和供應策略。

區域趨勢對商業化策略和產品開發重點均有顯著影響。在美洲，成熟的醫院基礎設施、廣泛的私立醫院網路以及不斷擴大的門診手術能力正在塑造市場需求趨勢，為現有的基於聚甲基丙烯酸甲酯（PMMA）的產品以及新興的、用於控制感染和促進骨整合的生物活性配方創造了機遇。該地區完善的採購流程有助於建立長期的供應商關係和系統化的合約機制，這些機制重視實證績效和可靠的供應鏈。

競爭格局概述，展示了成熟企業、專業創新者和通路夥伴如何塑造其產品差異化和打入市場策略。

骨水泥和外科黏合劑領域的競爭動態由成熟製造商、專業生醫材料公司、契約製造以及專注於下一代生物活化技術的創新Start-Ups共同構成。成熟企業受益於與大規模醫院系統的緊密合作關係、廣泛的企業發展以及在多個司法管轄區獲得監管核准的經驗。這些成熟企業通常利用規模經濟來最佳化生產成本，投資於臨床證據的開發，並提供包含儀器和培訓在內的成套解決方案。

在不斷變化的醫療保健環境中，製造商和供應商需要採取具體的策略重點來增強臨床差異化、供應韌性和商業性擴充性。

骨水泥和黏合劑產業的領導企業應採取多管齊下的策略，以提升產品卓越性、增強供應鏈韌性並適應不斷變化的臨床路徑。首先，應投資於臨床證據項目，以產生真實世界的結果數據，證明其不僅符合監管要求，還能降低感染率、提高植入穩定性並縮短患者康復時間。這些數據有助於在採購談判中提出差異化的價值提案，並有助於將產品納入醫院處方集和優選供應商名單。

為了確保實踐的嚴謹性，我們採用了穩健的混合方法研究途徑，結合了對臨床醫生的訪談、對供應商的文件分析以及多方面的數據匹配。

本分析所依據的研究融合了定性和定量方法，以確保獲得全面且基於證據的見解。主要研究包括對整形外科、顱顏外科和牙科的臨床醫生、醫院和門診手術中心的採購經理、生物材料製造商的產品經理以及分銷商的高階主管進行結構化訪談。這些訪談直接揭示了影響產品選擇的臨床績效預期、採購決策者以及營運限制因素。

策略概述重點在於臨床表現、採購重點和供應彈性之間的整合，這將決定未來的市場領導。

總之，骨水泥和外科黏合劑市場正朝著兼具可靠的機械性能、生物活性和在各種手術環境中易於操作的解決方案方向發展。這項轉變的驅動力來自臨床對改善治療效果的需求、採購壓力對價值和供應韌性的重視，以及監管機構對病人安全和實證實踐的優先考慮。那些將產品開發與臨床工作流程相結合，並投資於擴充性且具有區域彈性的供應模式的相關人員，將更有利於把握新的機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 骨水泥和黏合劑市場：依產品類型分類

  • 丙烯酸骨水泥
    • 抗生素組合
    • 不含抗生素
  • 磷酸鈣水泥
    • 射出模具
    • 可塑性

第9章 骨水泥和黏合劑市場：依技術分類

  • 生物活性
    • 磷酸鈣
    • 矽酸鈣
  • PMMA型
    • 高黏度
    • 低黏度

第10章 骨水泥與黏合劑市場：依應用領域分類

  • 顱顎顏面
    • 重組手術
    • 創傷修復
  • 牙科
    • 植入
    • 維修
  • 整形外科
    • 骨折固定
    • 關節重建手術
    • 脊椎手術

第11章 骨水泥與黏合劑市場：依最終用戶分類

  • 門診手術中心
    • 多學科部門
    • 整形外科中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所
    • 牙醫診所
    • 門診復健

第12章 骨水泥與黏合劑市場：依通路分類

  • 直銷
    • OEM合作夥伴關係
    • 競標和合約
  • 銷售代理
    • 集團採購組織
    • 獨立銷售代理
  • 線上管道
    • 電子商務平台
    • 製造商網站

第13章 骨水泥和黏合劑市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 骨水泥與黏合劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 骨水泥和黏合劑市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國骨水泥與黏合劑市場

第17章：中國骨水泥和黏合劑市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • DePuy Synthes, Inc.
  • DJO Global, Inc.
  • Heraeus Medical GmbH
  • Medtronic plc
  • Paragon 28, LLC
  • Smith & Nephew plc
  • Stryker Corporation
  • TEI Biosciences, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-521BAA36EADE

The Bone Cement & Glue Market was valued at USD 2.11 billion in 2025 and is projected to grow to USD 2.25 billion in 2026, with a CAGR of 6.58%, reaching USD 3.29 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.11 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 3.29 billion
CAGR (%) 6.58%

A clarifying introduction to how biomaterial innovation and clinical workflow evolution are redefining bone cement and surgical adhesive selection

The bone cement and adhesive landscape is experiencing heightened attention from clinical, regulatory, and commercial stakeholders as advances in biomaterials converge with evolving surgical workflows. This report opens with an oriented introduction that situates bone cement and glue within contemporary orthopedic, craniofacial, dental, and spinal care pathways, clarifying how variations in composition, delivery formats, and end-user settings influence adoption and clinical outcomes.

Clinical teams increasingly demand materials that balance handling characteristics with biological performance. Consequently, the sector's product mix now spans traditional polymethyl methacrylate (PMMA)-based cements and newer bioactive chemistries designed to support tissue integration or deliver localized therapeutics. Meanwhile, distribution and procurement models are being reshaped by the rise of group purchasing organizations, tender-driven hospital contracts, and direct manufacturer relationships that prioritize long-term value and supply resilience.

From a buyer's perspective, technology selection is influenced by procedural complexity, setting capabilities, and reimbursement dynamics, leading to differentiated uptake across hospital operating rooms, ambulatory surgical centers, and specialty clinics. As a result, stakeholders must evaluate product portfolios not only on primary performance metrics but also on sterilization, storage, and in-procedure workflow compatibility. This introduction frames those dynamics and sets expectations for the deeper analysis to follow.

How advances in biomaterials, procedural migration to outpatient settings, and elevated regulatory requirements are reshaping market dynamics and clinical adoption

Over the past several years, transformative shifts have altered both the competitive and clinical landscapes for bone cements and surgical glues, driven by material science breakthroughs, procedural migration, and heightened regulatory scrutiny. Innovations in bioactive formulations have advanced from proof-of-concept to routine clinical evaluation, enabling materials that promote osteointegration and provide controlled resorption profiles. At the same time, improvements in delivery mechanisms, such as injectable and moldable formats, have expanded the range of minimally invasive and outpatient procedures that can reliably utilize these products.

Concurrently, there has been a steady movement of select procedures from inpatient settings to ambulatory surgical centers and specialty clinics, prompted by cost containment pressures and the drive to reduce hospital length of stay. This migration has pushed suppliers to refine packaging, sterilization, and handling features to suit lower-acuity settings where space and instrumentation differ from traditional OR environments. Transitioning procedural venues has also highlighted the importance of product ease-of-use and predictable performance under constrained time windows.

Regulatory expectations have intensified, particularly around safety labeling for antibiotic-loaded products and clinical data supporting long-term outcomes. As a result, companies are investing more heavily in clinical evidence generation and post-market surveillance. These combined shifts - material innovation, procedural migration, and regulatory focus - are creating new avenues for competitive differentiation while raising the bar for market entry and sustained commercial success.

Assessing how recent tariff measures have prompted strategic supply chain reconfiguration, sourcing regionalization, and commercial contracting shifts across the sector

The introduction of tariffs and trade policy changes in 2025 has created a measurable inflection point for supply chain strategies across the bone cement and glue sector. Import duties on intermediate inputs and finished devices have increased landed costs for manufacturers that rely on cross-border production of polymers, active additives, and packaging materials. In response, firms are reassessing sourcing strategies while accelerating regionalization of manufacturing capacity to reduce exposure to tariff volatility and to safeguard delivery timelines to key clinical customers.

As procurement teams adapt to higher input costs, there is stronger emphasis on value-based contracting and longer-term supply agreements that lock in pricing and service levels. This has intensified negotiations with distributors and group purchasing organizations, which are themselves recalibrating supplier portfolios to prioritize manufacturers with secure, near-shore production footprints. Consequently, companies without diversified manufacturing nodes or those dependent on single-source suppliers are under pressure to either secure alternative suppliers or to invest in localized production capabilities.

The tariff environment has also catalyzed innovation in packaging and product design to optimize transport efficiency and reduce weight- or volume-based duties. In parallel, firms are increasingly exploring toll manufacturing and licensing arrangements with regional partners to maintain market continuity while bypassing certain trade barriers. These strategic responses are not only tactical cost mitigations but also long-term decisions that influence competitive positioning, time-to-market for new formulations, and the resilience of supply chains amid shifting trade policies.

In-depth segmentation analysis reveals how product chemistry, clinical application, end-user settings, technology types, and distribution choices drive differentiated adoption pathways

Segmentation analysis reveals nuanced performance characteristics and adoption pathways that vary by product chemistry, clinical application, end-user setting, technology class, and distribution model. In terms of product type, the market encompasses acrylic bone cement and calcium phosphate cement; the acrylic segment is distinguished by antibiotic-loaded formulations and non-antibiotic variants that cater to infection control protocols and standard fixation needs respectively, while calcium phosphate alternatives are offered in injectable and moldable forms that respond to preferences for minimally invasive delivery or intraoperative shaping.

When viewed through the lens of application, clinical demand is distributed across craniomaxillofacial, dental, and orthopedic specialties. Craniomaxillofacial indications focus on reconstructive surgery and trauma repair with an emphasis on contour restoration and fixation; dental applications span implantology and restorative procedures where biocompatibility and handling impact osseointegration; orthopedic uses cover fracture fixation, joint replacement, and spinal surgery, each with distinct mechanical and biological performance imperatives that inform material selection.

End-user differentiation is significant: ambulatory surgical centers-comprising multi-specialty and orthopedic centers-prioritize quick-setting, easy-to-handle systems that align with accelerated throughput, whereas hospitals, both private and public institutions, demand versatility across complex procedures and compatibility with institutional purchasing protocols. Specialty clinics, including dental clinics and outpatient rehabilitation centers, require smaller package formats and user-friendly delivery systems tailored to high-volume, outpatient workflows.

Technology segmentation separates bioactive approaches from PMMA-based platforms. Bioactive technologies include calcium phosphate and calcium silicate variants designed to interact with host tissue and promote healing, while PMMA-based solutions present high-viscosity and low-viscosity options chosen for their mechanical stability and handling characteristics. From a distribution perspective, direct sales arrangements-built on OEM relationships and tender contracts-favor large institutional customers, distributors operate through group purchasing organizations and independent channels to reach a broader base, and online channels, comprising e-commerce platforms and manufacturer websites, are increasingly important for small-volume purchasers and quick replenishment. Together, these segmentation axes create a matrix of demand signals that manufacturers and suppliers must decode to align product development, marketing, and sales strategies effectively.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, regulatory priorities, and supply strategies

Regional dynamics materially influence both commercialization strategies and product development priorities. In the Americas, demand trends are shaped by a mature hospital infrastructure, expansive private hospital networks, and growing outpatient surgical capacity, which together create opportunities for both established PMMA-based products and emerging bioactive formulations that address infection control and osteointegration. The region's procurement sophistication encourages long-term supplier relationships and structured contracting mechanisms that reward evidence-backed performance and reliable supply chains.

In Europe, Middle East & Africa, regulatory harmonization and diverse healthcare models create a complex mosaic of adoption curves. Western European markets demand rigorous clinical data and often serve as launchpads for advanced bioactive materials, while markets in other parts of the region may emphasize cost-effectiveness and supply chain adaptability. Emerging markets within this region present growth potential driven by infrastructure investment and expanding access to surgical care, yet they require tailored distribution approaches and flexible pricing structures.

The Asia-Pacific region is characterized by a broad spectrum of market maturity, with high-volume centers in urban hubs adopting sophisticated materials and delivery systems, and peripheral settings prioritizing affordability and ease of use. Local manufacturing hubs and a thriving medtech innovation ecosystem in several countries are accelerating product localization and customization. Across all regions, supply chain resilience, regulatory alignment, and the ability to demonstrate clinical and economic value remain decisive factors for sustained adoption and market penetration.

Competitive landscape overview showing how incumbents, specialized innovators, and channel partners shape product differentiation and market access strategies

Competitive dynamics in the bone cement and surgical glue ecosystem are defined by a mixture of legacy manufacturers, specialty biomaterials firms, contract manufacturers, and innovative startups focused on next-generation bioactive chemistries. Established players benefit from entrenched relationships with large hospital systems, extensive commercial footprints, and experience with regulatory approvals across multiple jurisdictions. These incumbents often leverage scale to optimize manufacturing costs, invest in clinical evidence development, and offer bundled solutions that include instrumentation and training.

At the same time, midsized and emerging firms are differentiating through focused investments in niche technologies such as antibiotic-loaded cements with refined elution profiles, calcium phosphate systems designed for specific orthopedic niches, and high-precision delivery platforms that reduce intraoperative variability. Contract manufacturing organizations play an increasingly strategic role by enabling smaller innovators to scale production while managing quality systems and regulatory compliance.

Distribution partners, including national distributors and group purchasing organizations, act as gatekeepers to hospital formularies and ambulatory networks; their influence over purchasing decisions underscores the importance of channel strategies that balance direct sales relationships with broader distribution agreements. Partnerships and licensing arrangements are common as faster time-to-market and local regulatory alignment become priorities. Overall, competitive success hinges on a company's ability to demonstrate clinical differentiation, maintain supply continuity, and engage with stakeholders across procurement, clinical practice, and hospital leadership.

Actionable strategic priorities for manufacturers and suppliers to strengthen clinical differentiation, supply resilience, and commercial scalability in evolving care settings

Leaders in the bone cement and glue sector should adopt a multi-pronged strategy that addresses product excellence, supply chain resilience, and alignment with evolving clinical pathways. First, invest in clinical evidence programs that not only meet regulatory requirements but also generate real-world outcomes data demonstrating improvements in infection rates, implant stability, and patient recovery timelines. Such data supports differentiated value propositions during procurement negotiations and facilitates placement on hospital formularies and preferred vendor lists.

Second, diversify manufacturing and sourcing footprints to mitigate trade policy exposures and to ensure continuity of supply for critical hospital customers. This may include pursuing regional manufacturing partnerships, tolling agreements, or selective near-shoring to reduce lead times and tariff impacts. In tandem, optimize packaging and logistics to minimize transport costs and to meet the specific needs of ambulatory and outpatient settings where space and instrumentation differ from traditional operating theaters.

Third, refine commercial models to balance direct sales with distributor partnerships and digital channels. Direct engagement with large institutional buyers remains important for complex offerings, while distributors and online platforms can extend reach into smaller clinics and dental practices. Additionally, prioritize training and education programs that simplify product handling and demonstrate procedural efficiencies; clinicians value hands-on support and evidence-backed protocols that reduce intraoperative uncertainty.

Finally, pursue targeted R&D focused on user-centric product features such as adjustable setting times, improved radiopacity, and compatible delivery tools. Complement product development with strategic collaborations that accelerate clinical validation and regulatory approvals. Taken together, these actions will strengthen market positioning and create durable competitive advantage as clinical and procurement landscapes continue to evolve.

Robust mixed-methods research approach combining clinician interviews, supplier documentation analysis, and multi-source data triangulation to ensure actionable rigor

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure comprehensive, evidence-based insights. Primary research consisted of structured interviews with clinicians across orthopedics, craniofacial surgery, and dentistry, procurement leaders from hospitals and ambulatory surgical centers, product managers from biomaterials companies, and distribution executives. These conversations provided direct perspectives on clinical performance expectations, procurement decision drivers, and operational constraints that shape product selection.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available clinical study summaries to validate material properties, performance claims, and safety profiles. In addition, supplier documentation, product IFUs, and clinical technique guides were analyzed to assess handling characteristics and usage protocols. Data triangulation combined insights from primary interviews with secondary sources to identify convergent themes and to reconcile conflicting viewpoints.

Analytical techniques included thematic coding of qualitative transcripts, comparative feature mapping across product types and technologies, and scenario analysis to evaluate the impact of supply chain disruptions and policy shifts. Quality assurance steps encompassed cross-validation with multiple interviewees, peer review of draft findings by subject matter experts, and adherence to transparent documentation standards for data sources and methodological assumptions. This robust methodology ensures the findings offer both practical relevance and analytical rigor for stakeholders seeking to inform strategy and operational planning.

Strategic closing perspective highlighting the convergence of clinical performance, procurement priorities, and supply resilience that will determine future market leaders

In closing, the bone cement and surgical adhesive market is transitioning toward solutions that blend reliable mechanical performance with biological activity and practical handling for diverse procedural settings. This evolution is driven by clinical demand for improved outcomes, by procurement pressures that emphasize value and supply resilience, and by regulatory expectations that prioritize patient safety and evidence-based practice. Stakeholders that align product development with clinical workflows and that invest in scalable, regionally resilient supply models will be best positioned to capture emerging opportunities.

As the sector advances, success will increasingly depend on the ability to translate material science into executable clinical advantages-reducing infection risk, enhancing fixation, and improving patient recovery-while simultaneously navigating the complexities of distribution and procurement. Collaborative approaches that engage clinicians early in design, partner with regional manufacturers or contract manufacturers to secure supply, and employ data-driven value propositions will differentiate suppliers in a competitive landscape. Overall, the outlook favors those who can combine demonstrable clinical value with operational excellence and strategic agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Cement & Glue Market, by Product Type

  • 8.1. Acrylic Bone Cement
    • 8.1.1. Antibiotic Loaded
    • 8.1.2. Non Antibiotic Loaded
  • 8.2. Calcium Phosphate Cement
    • 8.2.1. Injectable
    • 8.2.2. Moldable

9. Bone Cement & Glue Market, by Technology

  • 9.1. Bioactive
    • 9.1.1. Calcium Phosphate
    • 9.1.2. Calcium Silicate
  • 9.2. PMMA Based
    • 9.2.1. High Viscosity
    • 9.2.2. Low Viscosity

10. Bone Cement & Glue Market, by Application

  • 10.1. Craniomaxillofacial
    • 10.1.1. Reconstructive Surgery
    • 10.1.2. Trauma Repair
  • 10.2. Dental
    • 10.2.1. Implantology
    • 10.2.2. Restorative
  • 10.3. Orthopedic
    • 10.3.1. Fracture Fixation
    • 10.3.2. Joint Replacement
    • 10.3.3. Spinal Surgery

11. Bone Cement & Glue Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Multi Specialty
    • 11.1.2. Orthopedic Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospital
    • 11.2.2. Public Hospital
  • 11.3. Specialty Clinics
    • 11.3.1. Dental Clinics
    • 11.3.2. Outpatient Rehab

12. Bone Cement & Glue Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. OEM Relationships
    • 12.1.2. Tender Contracts
  • 12.2. Distributors
    • 12.2.1. Group Purchasing Organizations
    • 12.2.2. Independent Distributors
  • 12.3. Online Channels
    • 12.3.1. E Commerce Platforms
    • 12.3.2. Manufacturer Website

13. Bone Cement & Glue Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bone Cement & Glue Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bone Cement & Glue Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bone Cement & Glue Market

17. China Bone Cement & Glue Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. DePuy Synthes, Inc.
  • 18.7. DJO Global, Inc.
  • 18.8. Heraeus Medical GmbH
  • 18.9. Medtronic plc
  • 18.10. Paragon 28, LLC
  • 18.11. Smith & Nephew plc
  • 18.12. Stryker Corporation
  • 18.13. TEI Biosciences, Inc.
  • 18.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE CEMENT & GLUE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BONE CEMENT & GLUE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 313. GCC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. GCC BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. GCC BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 316. GCC BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 317. GCC BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. GCC BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 319. GCC BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 320. GCC BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. GCC BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 322. GCC BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 323. GCC BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 324. GCC BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. GCC BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 326. GCC BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 327. GCC BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 328. GCC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. GCC BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)

TA